ArticleCNS neuroscience & therapeutics2014

In vivo administration of TLR9 agonist reduces the severity of experimental autoimmune encephalomyelitis. The role of plasmacytoid dendritic cells and B lymphocytes.

Ana Leda F Longhini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.